New analysis of ATH434-201 double blind trial strengthens efficacy signal at high dose level Positive data from ATH434-202 open-label trial demonstrates similar treatment effect in advanced MSA as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback